Cargando…
ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
Obesity-related glomerulopathy is a secondary glomerular disease and its incidence has been increased globally in parallel with the obesity epidemic. ORG emerged as a growing cause of end-stage renal disease in recent years. Unbalanced production of adipokines at the adipose tissue as well as low-gr...
Autores principales: | Chen, Yin-Yin, Hong, Han, Lei, Yu-Ting, Zou, Jia, Yang, Yi-Ya, He, Li-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523180/ https://www.ncbi.nlm.nih.gov/pubmed/36180463 http://dx.doi.org/10.1038/s41420-022-01191-2 |
Ejemplares similares
-
Correction: ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
por: Chen, Yin-Yin, et al.
Publicado: (2023) -
Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target
por: Wei, Lifang, et al.
Publicado: (2021) -
Glomerulopathy Associated With Moderate Obesity
por: Okabayashi, Yusuke, et al.
Publicado: (2016) -
IgM exacerbates glomerular disease progression in complement induced glomerulopathy
por: Panzer, Sarah E., et al.
Publicado: (2015) -
Viral Glomerulopathy
por: Deoliveira, Margaret, et al.
Publicado: (2023)